Aurobindo Pharma Limited — Others, 05-02-2025: Action(s) initiated or orders passed

Aurobindo Pharma has received a significant order from the Additional Commissioner of Central Tax, demanding GST of ₹77.61 crore and imposing a parallel penalty of the same amount for the period of 2017-18 to 2021-22. The company has already paid ₹23.72 crore under protest and reversed ₹8.78 crore of ITC for appropriation. The authority's order stems from allegations of receiving excess IGST refunds and non-reversal of ITC. Aurobindo intends to appeal this decision. While the immediate financial impact is deemed non-material, this update may provoke cautious sentiment among investors, given the scale of the claim.